Xiaobin Mei
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Injured proximal tubule-driven paracrine signaling promotes lipid-associated macrophage expansion and chondroitin sulfate biosynthesis via PPARG/TCF12 in diabetic kidney disease.
Journal: Frontiers in immunology
Published: May 15, 2026
Soluble guanylate cyclase modulators-a novel therapeutic approach for diabetic kidney disease.
Journal: Renal failure
Published: January 04, 2026
Application of scenario simulation based on boppps model in physical diagnostics--a practical exploration of integrated teaching mode for cardiac physical examination and electrocardiogram.
Journal: BMC medical education
Published: June 11, 2025
Risk factors for rapid kidney function decline in diabetes patients.
Journal: Renal failure
Published: September 11, 2024
A bifunctional fusion protein protected against diabetic nephropathy by suppressing NLRP3 activation.
Journal: Applied microbiology and biotechnology
Published: October 19, 2022
Simultaneous blockade of VEGF-B and IL-17A ameliorated diabetic kidney disease by reducing ectopic lipid deposition and alleviating inflammation response.
Journal: Cell death discovery
Published: September 20, 2022
An updated clinical prediction model of protein-energy wasting for hemodialysis patients.
Journal: Frontiers in nutrition
Published: May 01, 2022
Protective effects of interleukin-22 on oxalate-induced crystalline renal injury via alleviating mitochondrial damage and inflammatory response.
Journal: Applied microbiology and biotechnology
Published: October 07, 2021
A Novel Bifunctional Fusion Protein, Vunakizumab-IL22, for Protection Against Pulmonary Immune Injury Caused by Influenza Virus.
Journal: Frontiers in immunology
Published: June 20, 2021
IL-22-mediated renal metabolic reprogramming via PFKFB3 to treat kidney injury.
Journal: Clinical and translational medicine
Published: September 18, 2020
VEGF-B antibody and interleukin-22 fusion protein ameliorates diabetic nephropathy through inhibiting lipid accumulation and inflammatory responses.
Journal: Acta pharmaceutica Sinica. B
Published: April 17, 2020
Last Updated: 09/26/2026